Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: February 5, 2021

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Presented: May 5, 2020

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

Presented: April 30, 2020

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Presented: April 29, 2020

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Presented: April 28, 2020

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

Presented: April 9, 2020

NeoGenomics Provides COVID-19 Business Update

Presented: April 3, 2020

NeoGenomics Integrates HALO(R) From Indica Labs

Presented: April 1, 2020

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

Presented: March 2, 2020

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

Presented: February 28, 2020

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

Presented: February 27, 2020

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter